NMDA Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine Vielzahl von NMDA-Antikörpern für die Untersuchung von N-Methyl-D-Aspartat-Rezeptoren in verschiedenen physiologischen und pathologischen Prozessen. Die monoklonalen NMDA-Antikörper sind validiert für Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffineinbettungen (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA). N-Methyl-D-Aspartat-Rezeptoren spielen eine grundlegende Rolle bei der synaptischen Plastizität, beim Lernen und beim Gedächtnis und sind daher von zentraler Bedeutung für die neurobiologische Forschung. Eine Dysregulation der NMDA-Rezeptoraktivität wird mit zahlreichen neurologischen Erkrankungen in Verbindung gebracht, darunter die Alzheimer-Krankheit, Schizophrenie und Epilepsie. Das Verständnis der Funktion und Modulation von NMDA-Rezeptoren eröffnet neue Möglichkeiten für die Entwicklung gezielter therapeutischer Ansätze. Monoklonale NMDA-Antikörper ermöglichen den präzisen Nachweis und die Charakterisierung von Rezeptorexpressionsmustern in verschiedenen neuronalen Geweben. Die Untersuchung der NMDA-Rezeptor-Signalwege liefert wertvolle Erkenntnisse über die synaptische Übertragung und die Mechanismen der Plastizität. Die NMDA-Rezeptor-Forschung bringt immer wieder neue Aspekte der neuronalen Kommunikation und Entwicklung ans Licht. Die monoklonalen Antikörper von Santa Cruz Biotechnology für NMDA-Rezeptoren unterstützen Forscher weltweit dabei, unser Verständnis von neurologischer Gesundheit und Krankheit zu verbessern.
Siehe auch...
ChemCruz™ Chemikalien NMDA Inhibitoren or NMDA Aktivatoren für die funktionelle Analyse zellulärer Antworten auf NMDA
NMDA Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
NMDAε1 Antikörper (E-4) | sc-515148 | mouse IgG2b κ | 23-76 (h) | WB, IP, IF, ELISA | m, r, h | 12 | ||
NMDAε1 Antikörper (D-8) | sc-390094 | mouse IgG1 κ | 31-69 (h) | WB, IP, IF, ELISA | m, r, h | 7 | ||
NMDAε2 Antikörper (A-8) | sc-365597 | mouse IgG2a κ | 27-76 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 26 | ||
NMDAε4 Antikörper (G-10) | sc-17822 | mouse IgG2a κ | 268-386 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
NMDAζ1 Antikörper (E-2) | sc-518043 | mouse IgG2b κ | 654-680 (h) | WB, IP, IF, ELISA | h | 1 | ||
NMDAζ1 Antikörper (F-10) | sc-518053 | mouse IgG2a κ | 653-682 (h) | WB, IP, IF, ELISA | m, r, h | 5 |
NMDA CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
NMDAε1 CRISPR/Cas9 KO Plasmid (h) | sc-400963 | h | Gene Knockout | GFP | 0 | ||
NMDAε1 CRISPR/Cas9 KO Plasmid (h2) | sc-400963-KO-2 | h | Gene Knockout | GFP | 0 | ||
NMDAε1 HDR Plasmid (h2) | sc-400963-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
NMDAε1 Double Nickase Plasmid (h) | sc-400963-NIC | h | Gene Knockout | Puromycin | 0 | ||
NMDAε1 Double Nickase Plasmid (h2) | sc-400963-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NMDAε1 CRISPR/Cas9 KO Plasmid (m) | sc-420689 | m | Gene Knockout | GFP | 0 | ||
NMDAε1 HDR Plasmid (m) | sc-420689-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NMDAε1 Double Nickase Plasmid (m) | sc-420689-NIC | m | Gene Knockout | Puromycin | 0 | ||
NMDAε1 Double Nickase Plasmid (m2) | sc-420689-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
NMDAζ1 CRISPR/Cas9 KO Plasmid (h) | sc-400593 | h | Gene Knockout | GFP | 0 | ||
NMDAζ1 Double Nickase Plasmid (h) | sc-400593-NIC | h | Gene Knockout | Puromycin | 0 | ||
NMDAζ1 Double Nickase Plasmid (h2) | sc-400593-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NMDAζ1 CRISPR/Cas9 KO Plasmid (m) | sc-420688 | m | Gene Knockout | GFP | 0 | ||
NMDAζ1 HDR Plasmid (m) | sc-420688-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NMDAζ1 Double Nickase Plasmid (m) | sc-420688-NIC | m | Gene Knockout | Puromycin | 0 | ||
NMDAζ1 Double Nickase Plasmid (m2) | sc-420688-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
NMDAε2 CRISPR/Cas9 KO Plasmid (h) | sc-400654 | h | Gene Knockout | GFP | 0 | ||
NMDAε2 HDR Plasmid (h) | sc-400654-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
NMDAε2 Double Nickase Plasmid (h) | sc-400654-NIC | h | Gene Knockout | Puromycin | 0 | ||
NMDAε2 Double Nickase Plasmid (h2) | sc-400654-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NMDAε2 CRISPR/Cas9 KO Plasmid (m) | sc-420690 | m | Gene Knockout | GFP | 0 | ||
NMDAε2 HDR Plasmid (m) | sc-420690-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NMDAε2 Double Nickase Plasmid (m) | sc-420690-NIC | m | Gene Knockout | Puromycin | 0 | ||
NMDAε2 Double Nickase Plasmid (m2) | sc-420690-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
NMDAε3 CRISPR/Cas9 KO Plasmid (h2) | sc-402942-KO-2 | h | Gene Knockout | GFP | 0 | ||
NMDAε3 HDR Plasmid (h2) | sc-402942-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
NMDAε3 Double Nickase Plasmid (h) | sc-402942-NIC | h | Gene Knockout | Puromycin | 0 | ||
NMDAε3 Double Nickase Plasmid (h2) | sc-402942-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NMDAε3 CRISPR/Cas9 KO Plasmid (m) | sc-420691 | m | Gene Knockout | GFP | 0 | ||
NMDAε3 HDR Plasmid (m) | sc-420691-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NMDAε3 Double Nickase Plasmid (m) | sc-420691-NIC | m | Gene Knockout | Puromycin | 0 | ||
NMDAε3 Double Nickase Plasmid (m2) | sc-420691-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
NMDAε4 CRISPR/Cas9 KO Plasmid (h) | sc-401683 | h | Gene Knockout | GFP | 0 | ||
NMDAε4 HDR Plasmid (h) | sc-401683-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
NMDAε4 Double Nickase Plasmid (h) | sc-401683-NIC | h | Gene Knockout | Puromycin | 0 | ||
NMDAε4 Double Nickase Plasmid (h2) | sc-401683-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NMDAε4 CRISPR/Cas9 KO Plasmid (m) | sc-420692 | m | Gene Knockout | GFP | 0 | ||
NMDAε4 Double Nickase Plasmid (m) | sc-420692-NIC | m | Gene Knockout | Puromycin | 0 | ||
NMDAε4 Double Nickase Plasmid (m2) | sc-420692-NIC-2 | m | Gene Knockout | Puromycin | 0 |
NMDA CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
NMDAε1 CRISPR Activation Plasmid (h) | sc-400963-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε1 CRISPR Activation Plasmid (h2) | sc-400963-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε1 Lentiviral Activation Particles (h) | sc-400963-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε1 Lentiviral Activation Particles (h2) | sc-400963-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε1 CRISPR Activation Plasmid (m) | sc-420689-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε1 CRISPR Activation Plasmid (m2) | sc-420689-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε1 Lentiviral Activation Particles (m) | sc-420689-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε1 Lentiviral Activation Particles (m2) | sc-420689-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAζ1 CRISPR Activation Plasmid (h) | sc-400593-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAζ1 CRISPR Activation Plasmid (h2) | sc-400593-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAζ1 Lentiviral Activation Particles (h) | sc-400593-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAζ1 Lentiviral Activation Particles (h2) | sc-400593-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAζ1 CRISPR Activation Plasmid (m) | sc-420688-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAζ1 CRISPR Activation Plasmid (m2) | sc-420688-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAζ1 Lentiviral Activation Particles (m) | sc-420688-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAζ1 Lentiviral Activation Particles (m2) | sc-420688-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε2 CRISPR Activation Plasmid (h) | sc-400654-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε2 CRISPR Activation Plasmid (h2) | sc-400654-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε2 Lentiviral Activation Particles (h) | sc-400654-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε2 Lentiviral Activation Particles (h2) | sc-400654-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε2 CRISPR Activation Plasmid (m) | sc-420690-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε2 CRISPR Activation Plasmid (m2) | sc-420690-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε2 Lentiviral Activation Particles (m) | sc-420690-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε2 Lentiviral Activation Particles (m2) | sc-420690-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε3 CRISPR Activation Plasmid (h) | sc-402942-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε3 CRISPR Activation Plasmid (h2) | sc-402942-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε3 Lentiviral Activation Particles (h) | sc-402942-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε3 Lentiviral Activation Particles (h2) | sc-402942-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε3 CRISPR Activation Plasmid (m) | sc-420691-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε3 CRISPR Activation Plasmid (m2) | sc-420691-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε3 Lentiviral Activation Particles (m) | sc-420691-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε3 Lentiviral Activation Particles (m2) | sc-420691-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε4 CRISPR Activation Plasmid (h) | sc-401683-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε4 CRISPR Activation Plasmid (h2) | sc-401683-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε4 Lentiviral Activation Particles (h) | sc-401683-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε4 Lentiviral Activation Particles (h2) | sc-401683-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε4 CRISPR Activation Plasmid (m) | sc-420692-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε4 CRISPR Activation Plasmid (m2) | sc-420692-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε4 Lentiviral Activation Particles (m) | sc-420692-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NMDAε4 Lentiviral Activation Particles (m2) | sc-420692-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
NMDA siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
NMDAε1 siRNA (h) | sc-36083 | h | Gene Silencing | N/A | 1 | ||
NMDAε1 shRNA Plasmid (h) | sc-36083-SH | h | Gene Silencing | Puromycin | 1 | ||
NMDAε1 shRNA (h) Lentivirale Partikel | sc-36083-V | h | Gene Silencing | Puromycin | 1 | ||
NMDAε1 siRNA (m) | sc-36084 | m | Gene Silencing | N/A | 3 | ||
NMDAε1 shRNA Plasmid (m) | sc-36084-SH | m | Gene Silencing | Puromycin | 3 | ||
NMDAε1 shRNA (m) Lentivirale Partikel | sc-36084-V | m | Gene Silencing | Puromycin | 3 | ||
NMDAε1 siRNA (r) | sc-270157 | r | Gene Silencing | N/A | 0 | ||
NMDAε1 shRNA Plasmid (r) | sc-270157-SH | r | Gene Silencing | Puromycin | 0 | ||
NMDAε1 shRNA (r) Lentivirale Partikel | sc-270157-V | r | Gene Silencing | Puromycin | 0 | ||
NMDAζ1 siRNA (h) | sc-36081 | h | Gene Silencing | N/A | 1 | ||
NMDAζ1 shRNA Plasmid (h) | sc-36081-SH | h | Gene Silencing | Puromycin | 1 | ||
NMDAζ1 shRNA (h) Lentivirale Partikel | sc-36081-V | h | Gene Silencing | Puromycin | 1 | ||
NMDAζ1 siRNA (m) | sc-36082 | m | Gene Silencing | N/A | 4 | ||
NMDAζ1 shRNA Plasmid (m) | sc-36082-SH | m | Gene Silencing | Puromycin | 4 | ||
NMDAζ1 shRNA (m) Lentivirale Partikel | sc-36082-V | m | Gene Silencing | Puromycin | 4 | ||
NMDAε2 siRNA (h) | sc-36085 | h | Gene Silencing | N/A | 1 | ||
NMDAε2 shRNA Plasmid (h) | sc-36085-SH | h | Gene Silencing | Puromycin | 1 | ||
NMDAε2 shRNA (h) Lentivirale Partikel | sc-36085-V | h | Gene Silencing | Puromycin | 1 | ||
NMDAε2 siRNA (m) | sc-36086 | m | Gene Silencing | N/A | 2 | ||
NMDAε2 shRNA Plasmid (m) | sc-36086-SH | m | Gene Silencing | Puromycin | 2 | ||
NMDAε2 shRNA (m) Lentivirale Partikel | sc-36086-V | m | Gene Silencing | Puromycin | 2 | ||
NMDAε2 siRNA (r) | sc-270104 | r | Gene Silencing | N/A | 0 | ||
NMDAε2 shRNA Plasmid (r) | sc-270104-SH | r | Gene Silencing | Puromycin | 0 | ||
NMDAε2 shRNA (r) Lentivirale Partikel | sc-270104-V | r | Gene Silencing | Puromycin | 0 | ||
NMDAε3 siRNA (h) | sc-42546 | h | Gene Silencing | N/A | 1 | ||
NMDAε3 shRNA Plasmid (h) | sc-42546-SH | h | Gene Silencing | Puromycin | 1 | ||
NMDAε3 shRNA (h) Lentivirale Partikel | sc-42546-V | h | Gene Silencing | Puromycin | 1 | ||
NMDAε3 siRNA (m) | sc-42547 | m | Gene Silencing | N/A | 0 | ||
NMDAε3 shRNA Plasmid (m) | sc-42547-SH | m | Gene Silencing | Puromycin | 0 | ||
NMDAε3 shRNA (m) Lentivirale Partikel | sc-42547-V | m | Gene Silencing | Puromycin | 0 | ||
NMDAε4 siRNA (h) | sc-36087 | h | Gene Silencing | N/A | 1 | ||
NMDAε4 shRNA Plasmid (h) | sc-36087-SH | h | Gene Silencing | Puromycin | 1 | ||
NMDAε4 shRNA (h) Lentivirale Partikel | sc-36087-V | h | Gene Silencing | Puromycin | 1 | ||
NMDAε4 siRNA (m) | sc-36088 | m | Gene Silencing | N/A | 0 | ||
NMDAε4 shRNA Plasmid (m) | sc-36088-SH | m | Gene Silencing | Puromycin | 0 | ||
NMDAε4 shRNA (m) Lentivirale Partikel | sc-36088-V | m | Gene Silencing | Puromycin | 0 |